Insider Trading: Amicus Therapeutics Inc (FOLD.W)

FOLD.W on CBOE When Trading NASDAQ Global Select Market

2.48USD
19 Jun 2013
Price Change (% chg)

$-0.05 (-1.98%)
Prev Close
$2.53
Open
$2.49
Day's High
$2.50
Day's Low
$2.43
Volume
1,100
Avg. Vol
2,104
52-wk High
$6.68
52-wk Low
$2.41

Search Stocks
NEWHALL CHARLES W III Options Exercised: 0
Trade Date: Tuesday, 6 Mar 2012 Price: 5.70
Title: Beneficial Owner of More than 10% Class Shares Held: 5,650,340
Type Traded: Indirect Net Change in Shares This Filing: 1,140,000
» More Insider Trading

Institutional Holders

% Shares Owned: 75.38%
# of Holders: 107
Total Shares Held: 37,409,911
3 Mo. Net Change: 2,220,151
# New Positions: 17
# Closed Positions: 11
# Increased Positions: 55
# Reduced Positions: 30
# Net Buyers: 25

Officers & Directors

Name Age Since Current Position

John Crowley

 45 2011 Chairman of the Board, Chief Executive Officer

William Baird

 2012 Chief Financial Officer

Geoffrey Gilmore

 46 2008 Senior Vice President, General Counsel, Secretary

Joan Winterbottom

 2012 Senior Vice President - Human Resources

David Lockhart

 50 2006 Chief Scientific Officer

Enrique Dilone

 45 2011 Vice President - Technical Operations

Robert Winkler

 46 2011 Vice President - Clinical Research and Operations

John Kirk

 55 2008 Vice President - Regulatory Affairs

Kenneth Peist

 48 2011 Vice President - Intellectual Property

Ken Valenzano

 44 2010 Vice President - Pharmacology

Daphne Quimi

 47 2010 Corporate Controller

Bradley Campbell

 36 2012 Chief Business Officer

Donald Hayden

 56 2010 Lead Independent Director

Sol Barer

 2009 Independent Director

M. James Barrett

 69 2009 Independent Director

Robert Essner

 66 2012 Independent Director

Ted Love

 53 2012 Independent Director

Margaret McGlynn

 53 2009 Independent Director

Michael Raab

 47 2004 Independent Director

Glenn Sblendorio

 57 2006 Independent Director

James Topper

 2004 Independent Director
Search Stocks